值得买：10月22日召开董事会会议

Company Summary - The company "值得买" (SZ 300785) announced on October 23 that its fourth board meeting was held on October 22, 2025, discussing the proposal for asset impairment provisions for the first three quarters of 2025 [1] - For the first half of 2025, the company's revenue composition is entirely from the internet and related services sector, accounting for 100.0% [1] - As of the report date, the market capitalization of "值得买" is 6.5 billion yuan [1] Industry Summary - The Chinese innovative pharmaceutical sector has seen significant overseas licensing sales, totaling 80 billion USD this year [1] - There is a contrast in the biopharmaceutical secondary market's activity, which is thriving, while the primary market is experiencing a cooling in fundraising [1]